Cancer site specific standardised mortality ratios among 74847 people hospitalised for diabetes, New Zealand, 1988 to 2001
| Cause of death ICD-9 | Maori (n = 11268) | Pacific (n = 5730) | Other (n = 57849) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Deaths | SMR | 95% CI | Deaths | SMR | 95% CI | Deaths | SMR | 95% CI | |
| Lip, oro-pharynx | |||||||||
| women | 3 | 3.46 | 0.71, 10.13 | 0 | – | 20 | 2.32 | 1.41, 3.58 | |
| men | 2 | 0.57 | 0.07, 2.06 | 2 | 0.88 | 0.11, 3.17 | 33 | 1.91 | 1.32, 2.69 |
| Oesophagus | |||||||||
| women | 4 | 2.13 | 0.58, 5.45 | 1 | 5.66 | 0.14, 31.44 | 29 | 1.48 | 0.99, 2.13 |
| men | 4 | 0.63 | 0.17, 1.61 | 3 | 3.64 | 0.75, 10.64 | 71 | 1.97 | 1.54, 2.48 |
| Stomach | |||||||||
| women | 25 | 3.10 | 2.01, 4.58 | 10 | 2.38 | 1.14, 4.38 | 54 | 1.88 | 1.42, 2.46 |
| men | 39 | 2.91 | 2.07, 3.98 | 4 | 0.59 | 0.16, 1.52 | 108 | 2.19 | 1.79, 2.64 |
| Colon | |||||||||
| women | 5 | 1.10 | 0.36, 2.57 | 3 | 1.45 | 0.30, 4.24 | 195 | 1.89 | 1.63, 2.17 |
| men | 17 | 2.27 | 1.32, 3.63 | 3 | 1.01 | 0.21, 2.96 | 233 | 2.21 | 1.94, 2.52 |
| Rectum | |||||||||
| women | 7 | 1.60 | 0.64, 3.30 | 5 | 2.75 | 0.89, 6.41 | 89 | 2.24 | 1.80, 2.76 |
| men | 15 | 2.09 | 1.17, 3.44 | 7 | 2.67 | 1.07, 5.51 | 132 | 2.08 | 1.74, 2.47 |
| Liver | |||||||||
| women | 12 | 5.78 | 2.98, 10.09 | 3 | 1.21 | 0.25, 3.54 | 36 | 4.29 | 3.01, 5.94 |
| men | 33 | 3.55 | 2.44, 4.98 | 9 | 1.80 | 0.82, 3.41 | 79 | 5.45 | 4.31, 6.79 |
| Pancreas | |||||||||
| women | 32 | 4.88 | 3.34, 6.89 | 4 | 2.29 | 0.62, 5.86 | 173 | 4.60 | 3.94, 5.34 |
| men | 25 | 3.40 | 2.20, 5.02 | 6 | 2.17 | 0.79, 4.72 | 197 | 4.75 | 4.11, 5.46 |
| Lung | |||||||||
| women | 150 | 2.70 | 2.29, 3.17 | 18 | 1.62 | 0.96, 2.56 | 273 | 2.69 | 2.38, 3.03 |
| men | 138 | 2.09 | 1.76, 2.47 | 38 | 1.64 | 1.16, 2.25 | 552 | 2.26 | 2.08, 2.46 |
| Melanoma | |||||||||
| women | 2 | 2.43 | 0.29, 8.77 | 1 | 7.46 | 0.19, 41.46 | 39 | 2.24 | 1.59, 3.06 |
| men | 0 | – | 0 | – | 66 | 2.01 | 1.56, 2.56 | ||
| Breast | |||||||||
| women | 41 | 1.98 | 1.42, 2.69 | 14 | 1.28 | 0.70, 2.14 | 298 | 2.60 | 2.31, 2.91 |
| Prostate | |||||||||
| men | 40 | 1.91 | 1.36, 2.60 | 21 | 1.84 | 1.14, 2.82 | 361 | 1.79 | 1.61, 1.99 |
| Bladder | |||||||||
| women | 3 | 1.99 | 0.41, 5.82 | 0 | – | 40 | 2.34 | 1.67, 3.19 | |
| men | 3 | 1.64 | 0.34, 4.80 | 3 | 2.54 | 0.52, 7.44 | 100 | 2.51 | 2.04, 3.05 |
| Kidney | |||||||||
| women | 6 | 4.15 | 1.52, 9.03 | 0 | – | 45 | 3.17 | 2.31, 4.24 | |
| men | 14 | 4.14 | 2.26, 6.94 | 3 | 2.56 | 0.53, 7.48 | 65 | 2.67 | 2.06, 3.40 |
| Brain | |||||||||
| women | 3 | 2.27 | 0.47, 6.64 | 2 | 1.31 | 0.16, 4.74 | 50 | 3.54 | 2.63, 4.66 |
| men | 4 | 2.04 | 0.56, 5.23 | 2 | 2.51 | 0.30, 9.05 | 62 | 2.93 | 2.25, 3.76 |
| Non-Hodgkin’s lymphoma | |||||||||
| women | 10 | 2.59 | 1.24, 4.76 | 8 | 2.63 | 1.13, 5.17 | 85 | 2.74 | 2.19, 3.38 |
| men | 9 | 2.24 | 1.02, 4.26 | 7 | 2.30 | 0.92, 4.73 | 112 | 2.86 | 2.35, 3.44 |
| Multiple myeloma | |||||||||
| women | 7 | 2.92 | 1.17, 6.02 | 5 | 2.73 | 0.88, 6.37 | 38 | 2.35 | 1.66, 3.23 |
| men | 17 | 4.20 | 2.44, 6.72 | 3 | 1.25 | 0.26, 3.67 | 42 | 2.00 | 1.44, 2.70 |
| Lymphoid leukaemia | |||||||||
| women | 4 | 4.03 | 1.10, 10.31 | 0 | – | 24 | 2.87 | 1.84, 4.27 | |
| men | 7 | 4.91 | 1.97, 10.12 | 0 | – | 34 | 2.57 | 1.78, 2.59 | |
| Myeloid leukaemia | |||||||||
| women | 5 | 2.38 | 0.77, 5.57 | 2 | 1.38 | 0.17, 4.99 | 44 | 3.28 | 2.38, 4.40 |
| men | 3 | 1.40 | 0.29, 4.10 | 3 | 1.85 | 0.38, 5.41 | 49 | 2.26 | 1.68, 2.99 |